Rationale Deficits in executive functions underlie compulsive drug use, and understanding how nicotine influences these cognitive processes may provide important information on neurobiological substrates of nicotine addiction. Accumulating evidence suggests that β2 subunit-containing nicotinic receptors (nAChRs) are involved in the reinforcing process of nicotine addiction. Whether these nAChRs also contributes to the detrimental effects of chronic nicotine on flexible decision-making is not known. Objectives In the present study, the effects of chronic nicotine were assessed in mice with partial or complete deletion of the β2 subunit-containing nAChR gene (β2+/− or β2−/−) performing an operant cognitive flexibility task. Results Visual discrimination learning was not affected in saline-treated β2 nAChR mutants as compared to the wildtype (β2+/+) mice; yet, chronic nicotine facilitated acquisition of visual discrimination in all genotypes. The acquisition of new egocentric response strategy set-shifting remained similar in all genotypes, and there was no effect of treatment. Chronic nicotine treatment impaired reversal learning in β2+/+ mice by increasing response perseveration to the previously rewarded stimulus. Moreover, the acquisition of inverted stimulus-reward contingencies did not differ between β2+/+ and β2−/− mice exposed to chronic nicotine. Interestingly, nicotine-induced reversal learning deficits were not observed in β2+/− mice. Conclusions Collectively, these findings suggest that β2 subunit-containing nAChRs are not critical for visual discrimination learning and extra dimensional rule shift. However, sustained activation of these nAChRs with nicotine may interfere with inhibitory control processes influencing affective shifts in stimulus-reward contingencies.
Introduction
Tobacco use continues to be one of the leading causes of preventable death worldwide and is considered a global health issue. Nicotine is one of the primary psychoactive ingredients associated with tobacco products and is also considered to largely contribute to developing addictive behaviors related to cigarette smoking. Although there are a large number of treatments targeted at smoking cessation, smokers attempting to quit continue to experience high rates of relapse (Hughes et al. 2008) . It is therefore pivotal that research continues to focus on the specific neural mechanisms of nicotine addiction.
Nicotine exerts its physiological and behavioral effects by binding to nicotinic receptors (nAChRs), which are a family of ligand-gated ionotropic receptors mediating fast synaptic transmission throughout the central nervous system. Neuronal nAChRs consists of heteropentameric assemblies of α2-α6 and β2-β4subunits, and homopentameric assemblies of α7-10 subunits (Gotti et al. 2006; Dani and Bertrand 2007) . Specifically, β2 subunit-containing nAChRs are known to modulate reward-motivated behaviors and may play a critical role in nicotine addiction (Changeux 2010) . For example, β2 nAChR null mutant mice did not self-administer nicotine (Picciotto et al. 1998 ); however, re-expression of this receptor subunit restored the nicotine self-administration response (Pons et al. 2008) . Rewarding effects of nicotine tested using the conditioned place preference paradigm were also not observed in mice lacking the β2 subunits of nAChRs (Walters et al. 2006) . Extensive evidence suggests that the reinforcing effects of nicotine primarily involve the activation of mesolimbic dopamine (DA) neurons in the ventral tegmental area (VTA) and consequent release of DA in striatal synapses via the high-affinity α4β2 nAChRs (Dani and De Biasi 2001; Laviolette and van der Kooy 2004; Leslie et al. 2013) . The presence of other β2 subunit-containing nAChRs such as α6α4β2 and α6β2 in the VTA has also been reported; these receptors persistently activate mesolimbic DA neurons by nicotine at smoking relevant concentrations (Grady et al. 2012; Liu et al. 2012 ) and produce nicotine-induced reinforcement (Pons et al. 2008) . Previous animal and human research indicates that chronic nicotine-induced neuroadaptations underlying dependence involves desensitization and long-lasting upregulation of α4β2 nAChRs contributing to heightened nicotine reward sensitivity and increase relapse vulnerability (Kenny and Markou 2006; Cosgrove et al. 2009; Hilario et al. 2012) . These findings suggest that β2-containing nAChRs contribute to the rewarding and reinforcing effects of nicotine.
In addition to modulating reward circuitry, stimulation of α4β2 nAChRs in other cortical-subcortical regions, such as the prefrontal cortex (PFC) and hippocampus, is linked to alterations in cognitive processes including attention (McGaughy et al. 1999; Howe et al. 2010; Guillem et al. 2011) , working memory (Levin et al. 2002; Chan et al. 2007) , and contextual fear learning (Kenny and Markou 2006; Portugal et al. 2008) . Due to the nature of overlap and interactions between the brain circuits underlying addiction and cognition, it is believed that these competing overlapping circuits produce an internal conflict between the rewarding effects of drugs and cognitive processes that suppress the urge to take drugs (Everitt and Robbins 2005; Robinson and Berridge 2008; Gould 2010) . Disruptions in these converging circuits may lead to the loss of cognitive control and produce maladaptive patterns of drug use in addicts (Kalivas and Volkow 2005; Volkow et al. 2011) . Because β2 subunitcontaining nAChRs are vastly distributed in these circuits (Gotti et al. 2007; Feduccia et al. 2012) , it is important to determine the contribution of these nAChR subtypes in chronic nicotine-induced alterations in cognitive control.
Cognitive flexibility is defined as the ability to switch strategic responses adaptively between changing environmental stimuli and is a fundamental component of frontoexecutive function used to probe cognitive dysfunction in addiction (Stalnaker et al. 2009; Izquierdo and Jentsch 2012) . We previously demonstrated that chronic nicotine treatment impaired reversal learning in C57BL/6J mice (Ortega et al. 2013) . In the present study, the effects of chronic nicotine were examined in mice lacking the β2 subunitcontaining nAChRs performing an operant cognitive flexibility task. This task required the animals to progress sequentially through multiple phases including visual discrimination, set-shifting, and reversal learning. Because the upregulation of nAChRs is linked to nicotine addiction (Govind et al. 2009) and it is not possible to determine whether nicotine-induced over activation of β2 subunit-containing nAChRs produce cognitive control deficits in null mutants, we utilized β2 nAChR heterozygous mice to test this hypothesis. Our results indicate that β2 nAChRs are neither involved in nicotineinduced facilitation of discrimination learning nor contribute to strategy set-shifting. However, β2 subunit-containing nAChRs do partially contribute to nicotine-induced impairments in reversal learning.
Materials and methods

Animals and genotyping
A mutant mouse line with the targeted deletion of the β2 subunit-containing nAChR gene was originally generated at the Baylor College of Medicine (Xu et al. 1999) . Chimeric mice were backcrossed for seven generations on the C57BL/6J background. A breeding pair of β2 nAChR heterozygous mice was generously provided by Dr. Arthur Beaudet (Baylor College of Medicine) and maintained on C57BL/6J mice for three additional generations prior to generating the wild-type (β2+/+), heterozygous (β2+/−), and knockout (β2−/−) mice. Mice were genotyped by subjecting the DNA extracted from tail biopsies to the PCR using the following primers: β2 wild-type forward, 5′-CTCTGACTGTAAAGGCAGTGGTTGCTATAG -3′; β2 wild-type reverse, 5′-TAGCTATTGACGACGTCTTTAAGA TCC -3′; and β2 mutant reverse, 5′-GAGACTAGTGAGAC GTGCTACTTCCATTTG -3′. The amplification products were 250 bp for the β2+/+, 400 bp for the null mutants, and both 250 and 400 bp for the heterozygous mice (Fig. 1a) .
Mice were group housed by sex post-weaning in a humidity/temperature-controlled colony room with a 12-h light/dark cycle (lights on at 07:00). One week prior to the beginning of experiments, wild-type and β2 nAChR mutant mice of either sex were individually housed and progressively water-restricted to 5-min of water/day. Animals were 8-9 weeks (weight, 20-24 g) old at the beginning of the task onset. All behavioral training and testing took place 7 days/ week between 9:00 and 16:00 hours. At the completion of each behavioral session, mice received 5 min of water in addition to sweetened water received as a reward for each correct response (see below). Food (PMI LabDiet) was available ad libitum throughout the experiment. All experimental procedures were approved by the Institutional Care and Use Committee (IACUC) of Temple University and were in accordance with the National Institute of Health guidelines.
Mouse operant procedure
Mouse operant conditioning chambers (MED Associates; St. Albans, VT, USA) equipped with a standard grid floor and house light (28 V, 100 mA) and a panel consisting of two large cue lights (2.5 cm; 28 V, 100 mV), a central reward port attached to a fluid dipper, and two ultra-sensitive retractable levers were used. Control of all events, including light presentation, lever operations, and reward delivery, utilized a SmrtCtrl interface running MED-PC IV software on Dell PC (Optiplex 960).
Mice were trained in an automated operant cognitive flexibility task as described previously (D'Amore et al. 2013; Ortega et al. 2013 ). This task places heavier emphasis on response conflicts and shares features similar to the operant tasks previously established to assess cognitive flexibility in rodents (Floresco et al. 2008; Haluk and Floresco 2009; Brigman et al. 2010; Scheggia et al. 2014) . Briefly, animals were autoshaped on a FR-1 schedule of reinforcement to acquire the lever press response and subsequent reward (10 μl of 0.066 % saccharin solution). After attaining at least 30 lever press responses with a 30-min session for three consecutive days, animals advanced to a pretraining phase that involved responding to an activated lever randomly associated with an unpredictably occurring illumination of the panel light within 10 s to get the reward. Mice were implanted with mini-osmotic pumps for chronic drug delivery (see below) after reaching pretraining criterion (30 rewards and ≤10 % omissions).
Mice that retained criterion following recovery were progressed sequentially to three different phases of training: visual discrimination, strategy set-shifting, and reversal learning (see Fig. 1b for schematic diagram of experiment). During the visual discrimination phase, mice were required to discern the lever with an activated cue light. The session began with the illumination of the house light and presentation of 30 trials with an ITI of 9±3 s. All trials were started with the illumination of α7 s visual cue (either from the left or right panel), followed by the presentation of both levers 2 s later. Levers were present for 5 s, and both the stimulus light and levers were co-terminated. A lever press response on the cued lever was scored as a "correct response" and was followed by reward delivery. Responses on the incorrect lever were not rewarded and resulted in a "timeout" (negative punishment) phase characterized by a 10-s extinguishing of the house light. Punishment on incorrect responses was introduced to discourage indiscriminate responding to levers. It is important to note that the ITI and punishment durations used for this study were selected to allow the animals to clearly distinguish between correct trials (i.e., reward+ITI) and incorrect trials (i.e., time out+ITI). The house light remained illuminated throughout the entire session except for the punishment phase. Animals trained to criterion (80 % correct responses for three consecutive days) were advanced to the next phases of training.
During the set-shifting phase, experimental parameters remained identical to the previous phase except that the contingencies were altered in such a way that the animals were required to adopt an egocentric response strategy to achieve rewards. Animals were required to press the correct lever (either left or right; lever assignment was counterbalanced within a group) to earn a reward irrespective of cue presentation which remained pseudorandom. Mice that successfully attained criterion at this stage of training were moved to the reversal learning phase. During this phase of training, the proprioceptive rule was reversed; animals were required to press the lever opposite of the one assigned to them during preceding phases irrespective of the position of the activated cue light. Daily training on 30-trial sessions continued until the animals attained criterion by exhibiting ≥80 % correct responses for three consecutive days on both the strategy set-shifting and reversal learning phases of the task.
Behavioral measures
The number of correct responses, errors, omissions, response latencies, and reward retrieval latencies was obtained for each behavioral session. Response accuracies were calculated for each session using the formula: correct responses/(correct+ incorrect responses)×100. The total number of performed trials to criterion, errors to criterion, and omissions were Fig. 1 Genotyping and general experimental design. a PCR-based genotyping strategy confirming amplified DNA fragments from the target gene. β2+/+ mice revealed a DNA product of 250 bp as compared to 400 bp for the β2−/− mice. β2+/− mice displayed both gene products at 250 and 400 bp, respectively. b Schematic representation of the experimental design. Animals of each genotype were initially autoshaped and then pretrained to press an activated lever within allotted time to receive reinforcement (see "Materials and methods"). Animals that reached pretraining criterion were implanted with subcutaneous osmotic minipumps (Alzet, Model #1004) to administer chronic nicotine (18 mg kg
) or saline for 28 days. Following recovery, mice were trained and tested for the retention of pretraining criterion. Animals that matched criterion performance were progressed through subsequent stages of the task (i.e., visual discrimination, strategy set-shifting, and reversal learning). The range of training days required to complete each stage of the task is indicated in the schematic. After completion of behavioral testing, serum samples were collected from few animals per genotype to determine cotinine levels obtained for each training phase using the above-described criteria. Strategy shifting performance was characterized by distinguishing whether an incorrect response occurred due to the perseverance of a previously learned strategy or failure to acquire/maintain a new strategy. Errors were classified as perseverative, regressive, and never-reinforced based on criterion reported in earlier studies (Floresco et al. 2008; Howe et al. 2010; D'Amore et al. 2013) . A perseverative error occurred if the animal responded to the incorrect lever when the visual cue was illuminated above it on ≥60 % of trials within a session. Depending on the training performance in the preceding session, an error was scored as a regressive error if the animal made <60 % incorrect responses in subsequent sessions. At this point, the animals were making fewer errors and considered to be inhibiting the previously learned strategy and acquiring the new strategy. Never-reinforced errors occur if an animal respond on the incorrect lever while the visual cue is presented from the opposite side. Both regressive and neverreinforced errors were categorized as "learning errors" as they reflected an index of the acquisition/execution of a new strategy. Errors during the reversal learning phase occur when the animal responded on the lever opposite to the assigned one. Reversal errors were classified as perseverative if the animals made ≥60 % incorrect lever presses on performed trials in a session. If the animals made <60 % incorrect responses, errors were scored as regressive (i.e., learning errors) in all subsequent sessions.
Chronic nicotine administration and experiments
Once the animals attained pretraining criterion, as described above, they were randomly assigned either to the saline or nicotine group. Twenty-four hours prior to surgeries, mice were given ad libitum water to prevent dehydration. Miniosmotic pumps (model 1004, DURECT Corp., Cupertino, CA, USA) designed to administer drug/vehicle solution at a rate of 0.11 μL/h for 28 days were used. Pumps were filled with 100 μL of either sterile saline or nicotine hydrogen tartrate (Sigma Co, St. Louis, MO, USA) dissolved in saline and implanted subcutaneously in isoflurane-anesthetized mice under aseptic surgical conditions. Nicotine was administered at a dose of 18 mg kg −1 day -1 (reported as free base) previously reported to desensitize nAChRs (Turner et al. 2010 Wilkinson et al. 2013 ) and produce reversal learning deficits in mice (Ortega et al. 2013) .
Pretraining was resumed 48 h after recovery. Once animals regained criterion performance at this phase (2-4 days), they were progressed through the subsequent stages of the task (i.e., visual discrimination, strategy set-shift, and reversal learning). Osmotic pumps remained implanted throughout the duration of the task that varied between 17 and 24 days across animals following the onset of visual discrimination training. One osmotic pump was sufficient to deliver nicotine throughout the acquisition of three task stages. Immediately following the last session of the task, blood samples were collected through intracardiac puncture and analyzed via a cotinine ELISA kit. A total of 52 mice (n=7-11/genotype/ treatment group; see Table 1 for sample sizes per group) received osmotic minipumps and acquired all the stages of the task.
Cotinine ELISA Cotinine, a major metabolite of nicotine, is used to quantify tobacco exposure due to its stability and longer half-life than nicotine (Jarvis et al. 1988; Benowitz 1996; Hatsukami et al. 2007 ). Immediately following the last session of the task, blood samples were collected through intracardiac puncture from mice randomly selected from each group (n=3-5/genotype/treatment group) to measure serum cotinine levels. Blood was allowed to coagulate for 30 min at room temperature following which samples were centrifuged at 3000×g for 10 min to collect the serum. Isolated serum was stored at −80°C until further analysis. To determine whether nicotine exposure differed between the earlier and later task stages, we also analyzed serum cotinine levels following 7 days of nicotine treatment. For this experiment, a separate cohort of naïve β2+/+ mice (n=4) received nicotine-containing mini-osmotic pumps and blood samples were collected 7 days later. Serum cotinine levels were quantified using an ELISA kit (Orasure Technology) as per recommendations from the manufacturer.
Statistical analysis
Statistical analysis was performed with SPSS/PC+V21.0 (IBM SPSS Software, Armonk, NY, USA). Data for trials to criterion, errors to criterion, error types, omissions, correct and incorrect response latencies, and cotinine levels were analyzed using two-way ANOVA, using treatment (two levels; nicotine or saline) and genotype (three levels: β2+/+, β2+/−, or β2−/ −) as between-subject variables. As prior statistical analysis did not indicate a main effect of sex (trials to criterion: F(1,40) <1.22, p>0.27 all stages; errors to criterion: F(1,40)<1.67, 
These animals were implanted with osmotic minipumps for chronic nicotine or saline delivery and progressed through all the stages of the cognitive flexibility task M: male, F: female p>0.20 all stages) or sex x genotype interaction (trials to criterion: F(2,40)<0.71, p>0.50 all stages; errors to criterion: F(2,40)<0.88, p>0.41 all stages), data between sexes were aggregated across all groups to increase the statistical power. Learning analyses were conducted by comparing response accuracies using mixed-factor repeated measures ANOVA with training sessions as the within-subject factor and treatment and genotype as the between-subject factors. For these analyses, response accuracy data for the first five training sessions was compared for each stage of the task. Post hoc comparisons were performed using the Tukey's honest significant difference (HSD) test. For all statistical tests, p values ≤0.05 were considered significant.
Results
Serum cotinine levels
Due to performance variability, the duration of the chronic nicotine exposure on average varied between 3 and 4 weeks following the acquisition of all three stages of the task. Serum cotinine concentration was 131.35, ±1.47 ng/mL in β2+/+ mice at the completion of behavioral testing. These values fall within the range of 100-200 ng/mL estimated in active smokers who consumes >3 cigarettes/day (Benowitz 1996) . Moreover, serum cotinine levels estimated after the completion of the study in chronic nicotine-treated β2+/+ mice remained similar to cotinine levels assessed in wild-type mice that received nicotine for 7 days (F(1,14)=1.36, p=0.26).
These data indicate that steady state nicotine concentration was presumably attained using subcutaneous mini-osmotic implants within a week. Absence of any difference in serum cotinine between the genotypes (F(2,14)=0.85, p=0.45) reflect that the rate of nicotine metabolism was not influenced by the level of β2 subunit-containing nAChR expression. Serum cotinine levels in saline-treated animals remained below detectable levels (<14 ng/mL).
Nicotine-induced facilitation of visual discrimination learning does not involve β2 subunit-containing nAChRs Chronic nicotine-treated mice required reduced number of trials to attain visual discrimination criterion as compared to saline-treated mice (main effect: F(1,46)=13.33, p<0.001; Fig. 2a) . Moreover, nicotine-exposed animals committed less errors (main effect: F(1,46) = 8.87, p = 0.005 vs saline; Fig. 2b Nicotine-induced reversal learning deficits were attenuated in β2 nAChR heterozygous mice
The main results on reversal learning performance are summarized in Fig. 3 . A 2×3 ANOVA on trials to criterion revealed no significant main effects of treatment (F(1,46)= 0.415, p=0.52) or genotype (F(2,46)=1.04, p=0.36), but a significant interaction was found between the two factors (treatment x genotype interaction: F(2,46)=3.26, p=0.04).
Although post hoc analysis using Tukey's HSD test could not locate the source of this interaction, we did observe a trend toward higher number of trials to criterion in nicotine-treated β2+/+ mice (p=0.09 vs saline-treated β2+/+ mice; Fig. 3a ).
Response accuracies for training sessions of all genotypes treated with saline or nicotine showing session-dependent learning are depicted in Fig. 3b-d (main effect of training sessions: F(4,184)=325.54, p<0.001). Although, learning rates did not differ by genotype (F(2,46)=2.05, p=0.14) or treatment (F(1,46)=0.72, p=0.40), mixed-factor ANOVAs revealed a significant interaction between the two factors (F(2,46)=5.89, p=0.005). A closer examination of response accuracy data shows a rightward shift of the learning curve in nicotine-treated wild-type mice reflecting reversal learning impairments. Average response accuracies were significantly lower in nicotine-treated β2+/+ animals as compared to the saline animals (saline: 64.9 %, ±2.9 %; nicotine: 51.3 %, ±2.8 %; p=0.003). This effect presumably may be interpreted to reflect difficulty in shifting strategies rather than deficits in the rate of incremental learning as session-dependent increases in response accuracy did not interact with the genotype (session x genotype interaction: F(4,184)=0.33, p= 0.95). Slower task acquisition was not observed in β2 nAChR heterozygous mice that received chronic nicotine treatment (p=0.99 vs saline-and p=0.003 vs nicotine-treated wild-type mice); in fact, learning performance was marginally better in these mice as compared to the saline-treated β2+/− mice (p= 0.1; Fig. 3c ). On the other hand, response accuracies in β2−/− mice treated with nicotine remained similar to β2+/+ mice given a similar treatment (p=0.28). Moreover, learning curves of saline-and nicotine-treated β2−/− mice seemed to overlap with each other (Fig. 3d) .
In terms of reversal errors, statistical analysis shows no main effects of treatment (F(1,46)=0.62, p=0.42) or genotype (F(2,46)=1.11, p=0.34), but an interaction between the two variables (F(2,46)=3.98, p=0.02). Multiple comparisons revealed that nicotine-treated β2+/+ animals committed more errors than their saline-treated β2+/+ counterparts (nicotine: 69.18, ±4.84; saline: 50.2, ±5.07; p=0.04; Fig. 3e ). However, this effect was not observed in chronic nicotine-treated β2+/− mice (p=0.97 vs saline-treated β2+/+ mice). Additionally, reversal errors remained substantially lower in nicotineexposed heterozygous mice as compared to the wild-type animals that received similar treatment (p=0.02), indicating that the former actually benefited from nicotine. Reversal errors in β2 null mutants remained similar to the wild-type mice exposed to chronic nicotine (p=0.69). A separate analysis on different types of reversal errors showed that chronic nicotine increased perseverative errors reflecting impairments in the ability to acquire previously learned strategy. This effect was primarily observed in the β2+/+ and β2−/− mice (treatment x genotype interaction: F(2,46) = 3.19, p = 0.05; see Fig. 3f for multiple comparisons). Again, perseverative errors remained substantially lower in nicotine-treated mice β2+/− mice exposed to nicotine (p<0.001), further explaining the lack of detrimental effects of nicotine on reversal learning. Regressive errors on the other hand show a different trend. Nicotine treatment significantly reduced regressive errors (main effect: F(1,46)=5.15, p=0.02). Moreover, the effect of genotype on this behavioral measure and its interaction with treatment approached significance (main effect: F(2,46)= 3.00, p=0.06; genotype x treatment interaction: F(2,46)= 2.61, p=0.08). It is evident from Fig. 3g that saline-treated β2 nAChR mutants committed more regressive errors during the reversal phase reflecting difficulty in acquiring new reward contingency. Chronic nicotine exposure seemed to attenuate the effect of β2 nAChR genotype on regressive errors.
Analysis of omissions for reversal learning showed no main effect of treatment (F(1,46)=0.01, p=0.99) or genotype (F(2,46)=0.08, p=0.92) but yielded a significant interaction (F(2,46)=3.87, p=0.02). Despite the fact that multiple comparisons did not attain significance presumably due to higher variability in the data, it is interesting to note that nicotine-treated β2+/+ mice exhibited a trend towards higher omissions (p=0.09 vs saline-exposed β2+/+ mice; Fig. 3h ). On the other hand, an inverse trend was noted for the nicotine-treated β2−/− nAChR mice; omissions remained marginally lower in these animals as compared to wild-type mice that received a similar treatment (p= 0.1). Absence of treatment and genotype effects on the speed of responding indicate that alterations in omissions were not influenced by sensorimotor processing (correct response latencies; main effects and interactions: F<2.18; p>0.12; incorrect response latencies; main effects and interactions: F<1.62; p>0.21).
Discussion
We utilized transgenic mice to determine the contribution of β2 subunit-containing nAChRs to chronic nicotine-induced alterations in cognitive flexibility. Mice were exposed to either nicotine or saline through the use of subcutaneous miniosmotic pumps and progressed through multiple stages of an operant task to receive reinforcement by (a) visually discriminating the stimulus, (b) switching to a response strategy while ignoring the visual stimulus, and (c) reversing the previously acquired strategy. We show that nicotine facilitates visual discrimination, and β2 subunit-containing nAChRs do not seem to play a critical role in this effect. The ability to shift from a visual cue-based strategy to a new egocentric response strategy remained unaltered in β2+/− and β2−/− mice. Although, chronic nicotine did not influence strategy shifting, it impaired reversal learning by increasing the prepotent responding to the previously rewarded stimulus. Deficits in the acquisition of rule reversal were not observed in chronic nicotine-treated β2+/− mice, but these cognitive impairments persisted in β2 nAChR null mutants.
Faster acquisition of visual discrimination training criterion in chronic nicotine-treated β2+/+ mice replicated our previous data that chronic nicotine facilitate this form of learning (Ortega et al. 2013 ). There is a plethora of evidence indicating that acute or subchronic nicotine administration exerts beneficial effects on attentional processes by activating nAChRs in rodents (Stolerman et al. 2000; Newhouse et al. 2004; Young et al. 2004 Young et al. , 2013 Pattij et al. 2007; Semenova et al. 2007; Amitai and Markou 2009 ). As attention serves as an important variable in discrimination learning by expediting the selection of goal-relevant stimuli from the environment (Lovejoy 1968; Muir 1996) , our data support the view that chronic nicotine may enhance fundamental attentional operations. However, visual discrimination learning was not impacted in β2+/− and β2−/− mice. Moreover, nicotine-induced facilitation of this form of learning persisted in these mutants. These data reflect that perhaps activation of β2 subunit-containing nAChRs is not mandatory for performance in discrimination-learning tasks that engages bottom-up attentional processes to support perceptual learning. This interpretation is supported by the idea that activation of α4β2 nAChRs supports top-down attentional processes and not performance under conditions requiring lower attentional demands (Howe et al. 2010; Sarter and Paolone 2011; Demeter and Sarter 2013) . Previous studies have demonstrated that mice with complete elimination of either the α7 homomeric or α5 subunit-containing nAChRs show impaired visual attention (Young et al. 2004 (Young et al. , 2007 Bailey et al. 2010) . Therefore, nicotine-induced activation of non-β subunit-containing nAChRs may still facilitate performance under conditions that do not tax attentional processes.
Attentional set-shifting functions are known to be affected with chronic psychostimulant exposure (Beveridge et al. 2008; Featherstone et al. 2008 ). In our study, these cognitive capacities were assessed using a strategy shifting paradigm that required mice to divert attention from one stimulus dimension (visual cue) that previously predicted reward to a new dimension (egocentric spatial location of the lever) to attain reinforcement. This type of behavioral shifting between discrimination strategies engages attentional set-shifting functions (Floresco et al. 2006; Ragozzino 2007) . In line with our previous study, chronic nicotine exposure did not affect the ability of β2+/+ mice to adapt to the new response strategy. These data are also in agreement with a human study that did not find effects of nicotine dependence on extradimensional set-shifting (Nesic et al. 2011) . Additionally, the acquisition of strategy shifting was not influenced by the β2 genotype; both saline-and nicotine-treated β2+/− and β2−/− mice suppressed the previously acquired strategy and executed the newer strategy to acquire the task similar to the wild-type mice. These data imply that β2 subunit-containing nAChRs are not critical in the formation of attentional sets but may be important for selective processing of task-relevant information under conditions of distractors as noted previously.
Deficits in cognitive control and response inhibition are commonly observed in drug addicts and contribute to compulsive behavior (Dalley et al. 2011; Izquierdo and Jentsch 2012) . The reversal learning task is a widely accepted paradigm that is used to measure the ability to abandon previously rewarding contingencies that interfere with newly presented contingencies (Kehagia et al. 2010; Laughlin et al. 2011; McCracken and Grace 2013) . In our task, the strategy shifting procedure served as response discrimination and the reinforcement contingencies were inverted during the reversal phase. Acquisition of the reversal of response discrimination was slower in chronic nicotine-treated β2+/+ mice. Moreover, these animals committed more perseverative errors than saline-treated β2+/+ mice, indicating that reversal learning deficits were primarily associated with exacerbation of prepotent responding to the previously reinforced stimulus. Together, these data suggest that chronic nicotine-induced reversal learning deficits reflect disruption of inhibitory control processes under a response-conflict condition. Previous studies that demonstrated behavioral disinhibition with chronic nicotine exposure further support this interpretation (Sacco 2001; Kolokotroni et al. 2012) . Since nicotine has also been shown to increase proactive interference (Dunnett and Martel 1990; Levin et al. 1997) , we cannot rule out the possibility that nicotine-induced reversal learning deficits might have occurred due to memory transfer from the previous stages of the task.
Chronic nicotine-treated β2+/− mutants did not exhibit reversal learning deficits; unlike β2+/+ mice, perseverative responding remained restrained in these animals and they successfully acquired the reversal of response discrimination strategy. In contrast, β2−/− mutants exposed to chronic nicotine displayed higher perseverance to the penultimate strategy similar to β2+/+ mice. As noted in the introduction, there have been numerous animal studies indicative of desensitization and compensatory upregulation of β2 subunit-containing nAChRs following chronic nicotine exposure (Marks et al. 1985; McCallum et al. 2006 ). Moreover, human postmortem studies have also shown higher densities of α4β2 nAChRs in the cortex and striatum of smokers (Perry et al. 1999; Staley et al. 2006) . Multiple corticostriatal circuits including distinct prefrontal regions, such as the orbitofrontal cortex, and discrete regions of the striatum are implicated in reversal learning (Ragozzino 2007; Schoenbaum et al. 2007; Clarke et al. 2008; Darvas and Palmiter 2011) , and these circuits are also disrupted in drug addicts (Volkow et al. 2011) . Therefore, we speculate that neuroadaptations in frontostriatal circuits produced by chronic nicotine-induced desensitization/ upregulation of β2 subunit-containing nAChRs may partly contribute to reversal learning deficits. Attenuation of chronic nicotine-induced reversal learning deficits in β2+/− mice might result from the restoration of α4β2 and other β2 subunit-containing nAChR densities similar to saline-treated wild-type mice. It is important to note that increases in epibatidine-binding sites reflecting higher densities of α4β2 nAChRs following chronic nicotine exposure has previously been demonstrated in β2 nAChR heterozygous mice; however, receptor upregulation was lower in these animals as compared to nicotine-treated wild-type mice (McCallum et al. 2006 ). This scenario is consistent with the view that partial blockade of α4β2 nAChRs with drugs like varenicline may offer therapeutic benefits for nicotine dependence (Coe et al. 2005; Crunelle et al. 2010) . However, the persistence of reversal learning deficits in chronic nicotine-treated β2−/− mice would suggest that besides β2 subunit-containing nAChRs, sustained activation and desensitization of non-β2 subunit-containing nAChRs may also be involved in these effects. Such an interpretation would still not explain the differences in reversal learning performance between β2+/− and β2−/− mice exposed to chronic nicotine. Therefore, the involvement of potential compensatory changes in β2−/− mice to possibly account for these behavioral effects may not be entirely dismissed.
Saline-treated β2 nAChR mutants displayed subtle impairments in the learning/execution of the new strategy during reversal learning. Moreover, β2−/− mice also omitted more trials during this stage of the task. Chronic nicotine administration eliminated genotype-dependent effects on regressive errors illustrating some beneficial learning effects of nicotine in these animals. Additionally, overall omissions that were markedly increased in nicotine-treated β2+/+ mice were significantly reduced in β2 null mutants. Collectively, these data suggest that endogenous β2 nAChR activation may play an essential role in the resolution of conflicting stimulusresponse reinforcement strategies that require motivation to reliably execute competing new response patterns. Moreover, chronic nicotine may moderate the consequences of β2 nAChR deficiency by supporting motivational and cognitive mechanisms via activation of non-β2 nAChRs.
There are some limitations that must not be ignored while interpreting our data. First, the nicotine exposure was different during the acquisition of multiple phases of the task. Although the treatment regimen and the sequence of task stages remained uniform across the genotypes, the rates of nAChR activation and desensitization may be influenced by the duration of nicotine exposure and affect the behavior in a different manner. In an ideal situation, the effect of genotype on performance at each task stage should be assessed after a specific treatment duration period. Second, our interpretation that blood nicotine levels attained a steady state and remained similar throughout the task was based on the observation that cotinine concentration did not differ in serum samples collected from two separate cohorts of animals: (a) treated with nicotine for 1 week and (b) that completed the entire behavioral study (∼3-4 weeks). Therefore, we cannot rule out if there were any fluctuations in blood nicotine levels during each task stage. Finally, our sample sizes were too small to reveal any sex effects on performance in the cognitive flexibility task. These data should be treated with caution and studies with a larger number of animals for each sex per genotype should be designed to study sex differences.
To conclude, the presented evidence illustrates that sustained activation of β2 subunit-containing nAChRs contributes to chronic nicotine-induced impairments in inhibitory control processes that are critical in reversing a stimulusreward association. As the value of the reward and punishment stimulus switched during reversals in our paradigm (see "Materials and methods"), these deficits could also reflect impairments in affective shifting. Attenuation of nicotineinduced reversal learning deficits in β2+/− mice suggest that a balanced activation of β2 subunit-containing nAChRs is required to adjust behavior in response to changing stimulus-reward contingencies. However, impairments in reversal learning persisted in nicotine-exposed mice with complete deletion of β2 subunit nAChR gene exemplifying the involvement of other nAChR subtypes in this detrimental effect. These findings are consistent with the view that sustained activation and desensitization states of multiple nAChRs, most likely α4β2 and α7 nAChRs, and functional coordination between nAChR subtypes may contribute to the behavioral effects of chronic nicotine (Besson et al. 2007; Picciotto et al. 2008; Changeux 2010; De Biasi and Dani 2011) . Further investigation is required to explore the interplay of multiple nAChR subtypes in producing neuroadaptations in the frontostriatal circuits and how these processes alter executive control during nicotine dependence.
